Single Mutation Creates Highly Specific Maltose Biosensor

The study, published in the journal Bioscience Nanotechnology, demonstrates that a single amino acid substitution in an existing trehalose/maltose biosensor is sufficient to alter its ligand binding specificity. By engineering a variant named Malefficent, the team created a tool that can distinguish maltose from trehalose and other structurally similar sugars, addressing a significant limitation in current analytical methods for disaccharide quantification.

The lead sensor, Tre-C04, is a single fluorescent protein biosensor derived from green fluorescent protein (GFP). In its native form, Tre-C04 exhibits dual specificity, responding to both trehalose and maltose by inducing fluorescence upon ligand binding. While this dual affinity allows for the quantification of both disaccharides at nanomolar levels, it limits the sensor’s utility in applications that require strict maltose specificity, such as specific quality control in food processing or medical diagnostics for metabolic disorders.

To address this limitation, the research team, including Haruto Honma, Rintaro Suzuki, and Shingo Kikuta, employed a structure-based approach to identify key residues involved in ligand binding. They utilized the DiffDock program to predict the binding interaction between the trehalose/maltose-binding protein and maltose, as a crystal structure for the maltose-bound state was previously unavailable. By superimposing the predicted maltose-bound structure with the known trehalose-bound structure using PyMOL software, the researchers identified eight amino acid residues that formed hydrogen bonds with both disaccharides. Among these, glutamic acid at position 17 (E17) and arginine at position 364 (R364) were highlighted as critical for binding interactions.

The study involved a series of mutagenesis experiments to test the hypothesis that specific amino acid substitutions could eliminate trehalose binding while retaining maltose recognition. Initial alanine scanning mutagenesis revealed that replacing E17, D70, D123, and R364 with alanine significantly reduced the sensor’s fluorescence response to both ligands. These results indicated that these residues play critical roles in ligand binding, with the substitution of E17 and D123 showing particularly pronounced effects on binding affinity. This experimental data provided the foundation for designing more specific variants through targeted substitutions.

Based on the structural similarities and side-chain compositions of the original residues, the researchers generated four specific mutants: Tre-C04_E17D, Tre-C04_E17Q, Tre-C04_D123E, and Tre-C04_D123N. The substitution of glutamic acid with aspartic acid at position 17 was chosen because aspartic acid has a similar side-chain structure but a shorter methylene group. This change was hypothesized to alter the spatial orientation of neighboring residues, thereby disrupting the hydrogen bonding network required for trehalose binding. The resulting variant, Tre-C04_E17D, exhibited minimal fluorescence changes in the presence of 1 mM trehalose but showed a significant increase of up to 109% in the presence of 1 mM maltose, indicating high specificity for the target disaccharide.

This variant was subsequently named Malefficent, or Maltose Efficient Fluorescent Sensor, for further in vitro characterization. The sensor demonstrated a dynamic detection range for maltose from 3 nanomolar to 10 micromolar, with a dissociation constant (Kd) of 295.1 nanomolar. The fluorescence signal peaked within five minutes of sample addition, providing a rapid detection system. Importantly, the presence of trehalose did not significantly interfere with the sensor’s ability to detect maltose; in the presence of 1 micromolar and 100 micromolar trehalose, the Kd for maltose remained at 246.4 nanomolar and 227 nanomolar, respectively, confirming the robustness of the specificity.

Substrate specificity tests further validated the performance of Malefficent. The sensor showed no fluorescence response to various monosaccharides and disaccharides, including sucrose, fructose, sorbitol, mannitol, raffinose, cellobiose, lactose, and galactose, all tested at 1 millimolar concentrations. A slight decrease in fluorescence was observed in the presence of glucose, which the authors attributed to a loosening of the GFP structure due to conformational changes as the monosaccharide binds to the trehalose/maltose pocket. Additionally, Malefficent did not respond to maltose-derived oligosaccharides such as isomaltose, maltitol, or maltotriose, further demonstrating its exclusive specificity for maltose.

The development of Malefficent represents a significant advancement in protein engineering for biosensor applications. Current analytical methods for maltose quantification, such as high-performance liquid chromatography (HPLC) and gas chromatography, require expensive equipment and skilled technicians. Simpler chemical methods are often limited by interference from other reducing sugars. While electrochemical and FRET-based biosensors offer alternatives, they often face challenges in detecting maltose at nanomolar levels or require complex dual-emission measurements. Malefficent overcomes these limitations by providing a user-friendly, single-fluorescent protein system that functions in raw samples without the need for purification.

The practical implications of this research extend to food processing, beverage quality control, and medical diagnostics. In the brewing industry, accurate and rapid quantification of maltose is essential for monitoring the quality of beer and other beverages. The ability of Malefficent to detect maltose in crude samples makes it particularly valuable for industrial applications where throughput and speed are critical. In medical contexts, the sensor’s ultra-high sensitivity could aid in the management of congenital sucrase-isomaltase deficiency, a rare genetic disorder that impairs the digestion of sucrose and maltose. By detecting trace amounts of maltose in food products, the sensor could support preventive dietary interventions for individuals with this condition.

The study also highlights the potential of structure-based prediction in guiding protein engineering. The use of DiffDock and AlphaFold2 to predict binding interactions and mutant conformations was instrumental in identifying the specific residues responsible for dual specificity. The targeted approach of modifying these residues proved more effective than random mutant screening, which the researchers noted did not yield satisfactory results.

Despite these successes, the study acknowledges certain limitations. The current strategy has not yet achieved a trehalose-specific sensor, indicating that further protein engineering is required to refine the functionality of the biosensor for other applications. Future advancements, such as genetic modifications to improve the dynamic range and fluorescence response, could lead to the development of even more versatile quantification tools. The researchers emphasize that while the in silico predictions were limited, they provided a crucial starting point for the experimental validation that led to the successful creation of Malefficent.

The work underscores the importance of integrating computational biology with experimental protein engineering to develop novel analytical tools. By leveraging the structural insights of the trehalose/maltose-binding protein, the team was able to precisely tailor the sensor’s binding properties. This approach not only solves a specific problem in maltose detection but also demonstrates the broader applicability of targeted mutagenesis in creating specialized biosensors.

The development of Malefficent provides a practical tool for researchers and industry professionals who require accurate and rapid maltose quantification.

Subject of Research: A single mutation is sufficient to alter ligand binding specificity in a trehalose/maltose genetically encoded fluorescent biosensor

Article Title: A single mutation is sufficient to alter ligand binding specificity in a trehalose/maltose genetically encoded fluorescent biosensor

Article References: Honma, H., Suzuki, R., & Kikuta, S. (2026). A single mutation is sufficient to alter ligand binding specificity in a trehalose/maltose genetically encoded fluorescent biosensor. Bioscience Nanotechnology, 2(1), Article 2. https://doi.org/10.1186/s44331-025-00008-0

Image Credits: AI Generated

DOI: 10.1186/s44331-025-00008-0

Keywords: single, mutation, sufficient, alter, ligand, binding, specificity, trehalose, maltose, genetically, encoded, fluorescent